Lung function decline in subjects with and without COPD in a population-based cohort in Latin-America
Lung-function decline is one of the possible mechanisms leading to Chronic Obstructive Pulmonary Disease (COPD). We analyzed data obtained from two population-based surveys of adults (n = 2026) conducted in the same individuals 5-9 years (y) after their baseline examination in three Latin-American c...
Uložené v:
| Vydané v: | PloS one Ročník 12; číslo 5; s. e0177032 |
|---|---|
| Hlavní autori: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Public Library of Science
04.05.2017
Public Library of Science (PLoS) |
| Predmet: | |
| ISSN: | 1932-6203, 1932-6203 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | Lung-function decline is one of the possible mechanisms leading to Chronic Obstructive Pulmonary Disease (COPD).
We analyzed data obtained from two population-based surveys of adults (n = 2026) conducted in the same individuals 5-9 years (y) after their baseline examination in three Latin-American cities. Post BronchoDilator (postBD) FEV1 decline in mL/y, as %predicted/y (%P/y) and % of baseline/y (%B/y) was calculated and the influence of age, gender, BMI, baseline lung function, BD response, exacerbations rate evaluated using multivariate models.
Expressed in ml/y, the mean annual postBD FEV1 decline was 27 mL (0.22%P, 1.32%B) in patients with baseline COPD and 36 (0.14%P, 1.36%B) in those without. Faster decline (in mL/y) was associated with higher baseline lung function, with significant response to bronchodilators, older age and smoking at baseline, also in women with chronic cough and phlegm, or ≥2 respiratory exacerbations in the previous year, and in men with asthma.
Lung function decline in a population-based cohort did not differ in obstructed and non-obstructed individuals, it was proportional to baseline FEV1, and was higher in smokers, elderly, and women with respiratory symptoms. |
|---|---|
| Bibliografia: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conceptualization: AMM RPP.Data curation: AMM RFP RPP.Formal analysis: RFP RPP.Funding acquisition: AMM MLV JRJ GV.Investigation: AMM MLV JRJ GV MMO RPP.Methodology: AMM RPP RFP.Project administration: AMM MVL GV JRJ AM MMO.Resources: AMM MVL GV JRJ AM.Supervision: AMM RPP MMO GV JRJ MLV AM.Writing – original draft: RPP RFP AMM.Writing – review & editing: RPP AMM RFP JRJ GV MMO AM MLV. Competing Interests: The study was sponsored by ALAT, Boehringer, GSK, and Novartis. This does not alter our adherence to PLOS ONE policies on sharing data and materials, in a public repository. Membership of the PLATINO group is provided in the Acknowledgments |
| ISSN: | 1932-6203 1932-6203 |
| DOI: | 10.1371/journal.pone.0177032 |